The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Monkey Pox Treatment Market Over The 2026–2030 Period?
The monkey pox treatment market size has experienced rapid growth in recent years. It is expected to expand from $0.1 billion in 2025 to $0.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The increase observed in the historic period can be attributed to past outbreaks in endemic regions, restricted access to vaccines, late diagnosis due to insufficient awareness, reliance on supportive care, and the worldwide spread during the 2022 outbreak.
The monkey pox treatment market is projected to expand significantly over the next few years. It is expected to reach $0.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period stems from factors such as the broadening of the antiviral pipeline, increasing global vaccination efforts, enhanced funding for infectious disease research, the implementation of improved diagnostic tools, and the expansion of government preparedness initiatives. Prominent trends for this period include the advancement of precision-based antiviral development, the integration of AI-powered models for outbreak forecasting, the expansion of digital tracking systems for case monitoring, the increased utilization of IoT-enabled disease surveillance networks, and a growing demand for sustainable vaccine production processes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp
Which Key Factors Are Driving The Monkey Pox Treatment Market Growth?
The escalating incidence of zoonotic infections is projected to fuel the expansion of the monkeypox treatment market going forward. A zoonotic infection is an illness transmitted from animals to humans through direct contact with contaminated environments or vectors. Heightened human-animal interaction, bringing people and animals into closer proximity, elevates the risks of zoonotic infection. Additionally, climate change intensifies this danger by broadening the ranges of disease vectors and introducing pathogens to new territories. Monkeypox treatments are utilized to manage zoonotic mpox by targeting the virus and alleviating symptoms in both humans and potentially infected animals. For instance, in August 2024, a report published by the UK Health Security Agency, a UK-based government agency, recorded 3,732 confirmed mpox cases in the UK, with the number rising by 21 to 3753 cases in 2023. Consequently, the increasing prevalence of zoonotic infection propels the monkeypox treatment market.
What Are The Different Segment Types In The Monkey Pox Treatment Market Segment Breakdown?
The monkey pox treatment market covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines, Therapeutics
2) By Dosage Forms: Solid, Liquid, Semi Solid
3) By Route Of Administration: Oral, Topical, Parenteral
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Prophylactic Vaccines: Vaccinia-Based Vaccines, Modified Vaccinia Ankara (MVA) Vaccines
2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir), Immune Modulators, Supportive Care Treatments
Which Trends Are Guiding The Direction Of The Monkey Pox Treatment Market?
Leading entities in the monkeypox treatment market are concentrating their efforts on creating novel solutions, like small-molecule antivirals, to improve worldwide health readiness and increase stockpile volumes. These antivirals work by suppressing particular viral proteins, thereby preventing the virus from disseminating internally, and their capability for extended storage positions them as excellent options for emergency scenarios. An example of this is SIGA Technologies, a US-based pharmaceutical firm, which obtained approval in Japan for its product TEPOXX (tecovirimat 200 mg capsules) in January 2025, becoming the inaugural antiviral medication for orthopoxviruses in the nation. This medication has exhibited a robust safety record, supported by findings from 15 clinical trials that included over 800 healthy participants. It also displayed measurable pharmacokinetics within effective dosage ranges and demonstrated significant preclinical effectiveness in animal studies, where it led to reductions in both death rates and viral quantities. Its mechanism involves blocking the VP37 protein found on the virus surface, which stops the virus from leaving infected cells, consequently allowing the immune system to eliminate the infection. SIGA has formed an exclusive distribution partnership with Japan Biotechno Pharma, aiming to establish Japan’s strategic national stockpile of TEPOXX.
Who Are The Well-Known Companies In The Monkey Pox Treatment Market?
Major companies operating in the monkey pox treatment market are Merck & Co Inc, Sanofi S A, Gilead Sciences Inc, BioNTech SE, Moderna Inc, Novavax Inc, Emergent BioSolutions Inc, Bavarian Nordic A S, SIGA Technologies Inc, Tonix Pharmaceuticals Holding Corp, Chimerix Inc, Emcure Pharmaceuticals Ltd, VBI Vaccines Inc, Pfizer Inc, Regeneron Pharmaceuticals Inc, GeoVax Labs Inc, Zydus Cadila Ltd, Serum Institute of India Pvt Ltd, Biological E Ltd, Dr Reddy’s Laboratories Ltd, Hester Bioscience Ltd, Indian Immunologicals Ltd, Reliance Life Sciences Pvt Ltd, Takeda Pharmaceuticals Co Ltd, KM Biologics Co Ltd, Meridian Bioscience Inc, NanoViricides Inc.
Get The Full Monkey Pox Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report
Which Region Has The Greatest Market Share In The Monkey Pox Treatment Market?
North America was the largest region in the monkey pox treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Monkey Pox Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report
Browse Through More Reports Similar to the Global Monkey Pox Treatment Market 2026, By The Business Research Company
Monkey Pox Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report
Infectious Disease Diagnostics Testing Market Report
Non Animal Alternatives Testing Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model